Trial
NCT01604031
Treatment of B-CLL With Autologous IL2 and CD40 Ligand-Expressing Tumor Cells + Lenalidomide
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Baylor College of Medicine
Collaborators
Center for Cell and Gene Therapy, Baylor College of Medicine; The Methodist Hospital Research Institute
Condition
B-cell Chronic Lymphocytic Leukemia
Intervention
B-CLL Vaccine
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-02-08